Comprehensive portfolio management solution designed to give pharmaceutical companies full visibility and control over the lifecycle of pricing and reimbursement procedures. The service provides continuous monitoring of administrative proceedings, proactive management of key milestones, and structured oversight of all regulatory interactions. MAiACCESS enables Market Access teams to streamline decision-making, mitigate procedural risks, and maintain a clear strategic overview across their entire product portfolio. 

Strategic pricing intelligence tool designed to help pharmaceutical companies maintain full control over external reference pricing across relevant markets. By systematically managing reference prices, monitoring cross-border dynamics, and evaluating real-time changes in pricing frameworks, MAiPRICES enables dynamic assessment of potential impacts on the entire product portfolio. 

Application designed to streamline the preparation, submission, and management of pricing and reimbursement applications. By guiding users through each step of the administrative process, standardizing documentation, and ensuring regulatory compliance, MAiREQUEST significantly reduces operational complexity and the risk of procedural errors.

Specialized intelligence and compliance tool designed to streamline the management of agreements published in the Czech Register of Contracts. By consolidating contract data, enabling targeted searches, and providing structured analytics, MAiCONTRACTS allows pharmaceutical companies to efficiently extract business-critical insights while monitoring confidentiality provisions and adherence to local regulatory requirements. The tool supports proactive risk management, strengthens internal governance, and ensures that pricing and contractual terms remain fully compliant across the entire portfolio. 

Provides pharmaceutical companies with a structured, data-driven view of the current decision-making patterns of the Czech HTA authority. By consolidating past assessments, identifying recurring arguments, and highlighting emerging regulatory trends, MAiPRECEDENT enables Market Access teams to anticipate likely outcomes and shape more effective pricing and reimbursement strategies and transforms fragmented public information into actionable strategic intelligence, supporting better preparation, stronger submissions, and more confident portfolio planning. 

OAKS is a leading Czech provider of Health Technology Assessment services, supporting pharmaceuticals, medical devices, and digital health technologies across the full spectrum of market access needs. With deep methodological expertise, robust analytical capabilities, and a strong understanding of the local regulatory environment, OAKS delivers high-quality assessments, strategic insights, and evidence-based guidance that help clients navigate complex reimbursement pathways and accelerate patient access. 

As one of the most trusted and highly regarded market access consultancies in the Czech Republic, OAKS provides end-to-end strategic and operational support to pharmaceutical and medtech companies. Operating either on a project-based model or as an external partner that fully substitutes for an internal market access department, OAKS delivers comprehensive expertise, seamless execution, and tailored guidance across the entire pricing, reimbursement, and HTA landscape. This flexible engagement model enables companies to strengthen their market access capabilities, accelerate delivery, and maintain consistently high standards of regulatory and strategic performance. 

OAKS provides fully customized training programs in market access and Health Technology Assessment, designed to strengthen the capabilities of both corporate teams and individual specialists. Leveraging deep methodological expertise and extensive practical experience, OAKS develops tailored workshops, strategic seminars, and hands-on training modules that reflect the latest regulatory expectations and real-world decision-making practices. This bespoke approach ensures that clients gain actionable knowledge, build internal competencies, and enhance their ability to navigate complex pricing, reimbursement, and HTA processes with confidence.